A case of suspected malignant hyperthermia during desflurane administration.
Michalek-Sauberer
A
A
Department of Anesthesiology and General Intensive Care, University of Vienna, Austria.
Fricker
R
R
Gradwohl
I
I
Gilly
H
H
D000293:Adolescent; D000764:Anesthesia, Closed-Circuit; D018685:Anesthetics, Inhalation / Q000009:adverse effects*; D002245:Carbon Dioxide / Q000097:blood; D002533:Cerebral Angiography; D003620:Dantrolene / Q000627:therapeutic use; D000077335:Desflurane; D004621:Embolization, Therapeutic; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy; D007530:Isoflurane / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008305:Malignant Hyperthermia / Q000188:drug therapy / Q000209:etiology*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010100:Oxygen / Q000097:blood; D012119:Respiration / Q000187:drug effects
D018685:Anesthetics, Inhalation; D009125:Muscle Relaxants, Central; D002245:Carbon Dioxide; D000077335:Desflurane; D007530:Isoflurane; D003620:Dantrolene; D010100:Oxygen